I know I know =), a strategic acquisition requiring a gargantuan cap raise with a target price of 0.05 to support the acquisition =). I'll stop here - I'm being too trollish and people might think im serious by accident. Sounds a lot like "We are getting more than one new clinic in partnership with someone else - cause if it was just one new one we wouldn't have to halt trading".
To be honest I am grateful for any release from them at the moment to soothe the intense pressure building in my throbbing bull.
Anyway I don't want to be too low effort here - so if anyone has any thoughts on:
1. How much they feel Openly - Emyrias smartphone observations monitoring platform - may be able to be used commercially in future? It is being used for EDICT (https://edict.org.au/about-project/meet-the-team/) and you can read more about EDICT here: https://www.brucerobinson.com.au/wp-content/uploads/2021/06/EDICT-Program.pdf. If they can gather a large amount of data and use it to make a more widely integrable vital signs monitoring it could be very lucrative if used by a service like HealthDirect or to flag patients who may need to attend hospital rather than book an appointment with a GP on a playform like HealthEngine.
2. Lets take a look at the evidence for CBD in IBS so that we can make our best guesses about how EMD-004 might go in future when looking at RX-5 for IBS.
Ultimately it looks like any good quality evidence is lacking - so emyria has a gap to fill to find out. Very interesting 2 case reports of refractory symptoms responding - https://www.scielo.br/j/jcol/a/HFWvsKJhpPdRzkHKhPjqqdM/?format=pdf&lang=en but thats far from good evidence. This very small study using CBD gummies (50mg individually capped at 300mg/day) did not have a significant finding https://library.wur.nl/WebQuery/wurpubs/fulltext/552895
Do we know what dose of RX-5 is being used in the EMD-004 trial?
- Forums
- ASX - By Stock
- Ann: Trading Halt
I know I know =), a strategic acquisition requiring a gargantuan...
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.004(12.5%) |
Mkt cap ! $11.45M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 2.7¢ | $16.60K | 551.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32777 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32777 | 0.028 |
4 | 117089 | 0.027 |
2 | 222222 | 0.026 |
1 | 54612 | 0.024 |
1 | 100000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 50000 | 1 |
0.034 | 57646 | 1 |
0.035 | 40000 | 1 |
0.037 | 70000 | 1 |
0.039 | 120000 | 2 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online